Research Paper Volume 13, Issue 6 pp 8155—8176
FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
Figure 7. The top 20 pathways were differentially enriched according to the level of NES in FAM72A-D related LUAD. (A–D) The enrichment plot was obtained from the gene set enrichment analysis (GSEA).